Support our Foundation of Myology project
1678 news items
Research
Risdiplam tablets approved at European level
On 19/06/2025
Already available in the oral solution form, which can be stored in the refrigerator or, exceptionally, at room temperature for up to 5 days, risdiplam…
Research
A case of acquired and reversible rod myopathy following leukaemia
On 19/06/2025
Researchers at the Créteil Neuromuscular Disease Reference Centre report the rather exceptional case of a patient who developed myopathic symptoms during an immunological complication (graft-versus-host…
Events
The corner stone of our Foundation of Myology was laid on 17 June
On 17/06/2025
On Tuesday 17 June, we laid the corner stone for our future Foundation of Myology, the first foundation worldwide dedicated to muscle research, in the…
Research
Exploring the infinitely small – Interview with Stéphane Vassilopoulos
On 16/06/2025
An expert in cell biology and molecular biology, Stéphane Vassilopoulos is co-director of the ‘Muscle cell organization and therapy of dominant centronuclear myopathy‘ team at…
Research
Va-C-Nemus reassures on the safety of vaccination against Covid-19 in NMD
On 16/06/2025
Launched in 2021, the Va-C-Nemus national prospective observational study involved 1,020 adults with a neuromuscular disease of genetic or autoimmune origin, 18% of whom were…
Events
M&M’s – Muscle Monday Seminar – 23 June – Eric Allemand (France)
On 16/06/2025
Regulation of transcriptome diversity through alternative splicing in hematological genetic disorders Monday 23 June 2025 – 12h00-13h00 Eric Allemand, PhD (Imagine Institute, Paris, France) More information on the…
Research
Seeing our muscles in action – Interview with Constantin Slioussarenko
On 12/06/2025
Constantin Slioussarenko, an engineer by training, is a researcher in the NMR and Spectroscopy Laboratory, co-directed by Harmen Reyngoud and Benjamin Marty, at the Neuromuscular…
Events
A look back at the 3rd edition of ‘Muscle Week’
On 12/06/2025
The 3ᵉ edition of Muscle Week, organised from 2 to 8 June 2025 by the Institute of Myology and AFM-Téléthon, mobilised researchers, healthcare professionals, the…
Research
Building the Muscle Atlas – Interview with Bruno Cadot
On 11/06/2025
Bruno Cadot is head of research in the ‘Signalling pathways and striated muscles’ team led by Antoine Muchir at the Center of Research in Myology…
Research
The evolution of the new Morimoto-Ruy-Malicdan syndrome described in two brothers
On 10/06/2025
In a previous study published in 2024, Marie Morimoto et al. described nine cases of a new congenital myopathy linked to biallelic variants of the…
Research
Towards a reassessment of certain contraindications to the use of drugs in autoimmune myasthenia gravis
On 03/06/2025
American researchers have investigated the possible complications associated with the use of several classes of antibiotics known to be harmful to myasthenia gravis patients: data…
Research
The association of dermatomyositis and encephalopathy is exceptional but should be noted
On 02/06/2025
Mexican clinicians report the clinical and immunological data of three patients with concomitant encephalopathy and dermatomyositis (DM): the three patients were adults in their fifties…
Research
Rising incidence of motor neurone disease in France before the Covid-19 crisis
On 30/05/2025
Using data from the French National Health Data System (SNDS), a French team has carried out a study of changes in the incidence of motor…
Research
No additional long-term beneficial effects for the bisoprolol-perindopril combination
On 28/05/2025
British clinicians report the long-term results of a prophylactic treatment for cardiomyopathy in Duchenne muscular dystrophy (DMD): the combination of perindopril (a conversion enzyme inhibitor)…
Documentation
Advances in myasthenia gravis – 2025
On 28/05/2025
This document presents a selection of myasthenia gravis research news stories from the past year (ongoing observational studies and clinical trials, scientific and medical publications…).…
Research
Variable severity of SMA in patients with four copies of the SMN2 gene
On 27/05/2025
A study published using data from the SMA France register, set up in 2020, shows a wide variety of phenotypes in patients with SMN1-related proximal…
Research
Towards conditional authorisation of givinostat in Europe for walking DMD patients aged 6 and over on corticosteroids
On 26/05/2025
Givinostat, a histone deacetylase (HDAC) inhibitor that acts on muscle fibrosis and inflammation in Duchenne muscular dystrophy, should be authorised in Europe very soon, under…
Research
A new non-invasive biomarker for investigating demyelinating neuropathies
On 23/05/2025
An international consortium led by researchers in Nantes has developed and studied in real life a new non-invasive method for demyelinating neuropathies such as CMT1A,…
Research
A model to predict the distance covered during the 6MWT in Pompe disease
On 22/05/2025
Researchers from the Laboratory of Physiology and Neuromuscular Evaluation at the Institute of Myology have developed and validated predictive models for the performance of the…
Events
ERN EURO-NMD webinar, 28 May: Dr. Nicol Voermans & Ria de Haas, PhD (the Netherlands)
On 22/05/2025
FSHD webinar series – Episode 4: “Clinical Trial Readiness” Wednesday 28 May 2025 – 16:00 – 17:00 Paris time Dr. Nicol Voermans & Ria de…